Transcatheter Closure of Perimembranous Ventricular Septal Defect Using the Amplatzer Duct Occluder II

作     者：Hongxiao Sun Gang Luo Zhanhui Du Zhixian Ji Silin Pan 

作者机构：Qingdao Women and Children’s HospitalQingdao UniversityQingdao266034China 

出 版 物：《Congenital Heart Disease》 (先天性心脏病（英文）)

年 卷 期：2021年第16卷第2期

页      面：151-157页

核心收录：

学科分类：1002[医学-临床医学] 100201[医学-内科学(含：心血管病、血液病、呼吸系病、消化系病、内分泌与代谢病、肾病、风湿病、传染病)] 10[医学] 

基　　金：The work was financially supported by the National Natural Science Foundation of China(81770316,81970249 to SLP) Shandong Taishan Scholarship(2018 to SLP)and Qingdao Science and Technology Plan(20-3-4-47-nsh) 

主　　题：Ventricular septal defect transcatheter closure Amplatzer duct occluder children 

摘      要：Objective:To evaluate the efficacy of Amplatzer duct occluder II(ADO II)in the treatment of perimembranous ventricular septal defect(pmVSD)in ***:Between June 2017 and June 2020,13 patients with pmVSD had attempted transcatheter closure using ADO II,seven of patients were used antegrade approach and six of them were used retrograde ***:There were 8 males and 5 females,age from 1 to 7 years,weight from 10.5 to 31.0 kg,and VSD size from 2.0 to 4.0 *** was successful in all cases with the outer diameter of the occluders ranging from 4 to 6 *** aortic,tricuspid regurgitation or residual shunt was found in the immediate ultrasound *** arrhythmia was observed in the Holter monitoring 3 days after the *** echocardiography indicated complete shunt *** evidence of occluder prolapse,malignant arrhythmia,or intensed valve regurgitation was seen on a median follow-up of 18 months(range,6 to 36 months).Conclusions:Based on our experience,ADO II showed good efficacy in the early and middle stages of pediatric pmVSD closures.